OCON Medical
Founded Year
2011Stage
Seed VC - II | AliveTotal Raised
$3.68MAbout OCON Medical
OCON Healthcare develops, manufactures, and commercializes cutting-edge women’s health products based on its patented IUB (Intra Uterine Ball) proprietary platform. The IUB, made from a super-elastic alloy Nitinol, is an ideal carrier for multiple drugs to the uterus to treat a variety of conditions.
OCON Medical's Product Videos
Compete with OCON Medical?
Ensure that your company and products are accurately represented on our platform.
OCON Medical's Products & Differentiators
IUB SEAD
OCON's IUB SEAD is a single-use, once-and-done method for endometrial ablation using silver nitrate beads that dissolve within 30 min. Simple and quick approach for AUB & HMB, which affects 1 in 3-4 women – now treated with either harmful hormones with recognized side effects or aggressive ablation therapies that may lead to hysterectomies. SEAD is a disruptive, non-hormonal, in-office, cost-effective solution. It is currently in phase IIb clinical studies.
Expert Collections containing OCON Medical
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
OCON Medical is included in 3 Expert Collections, including Medical Devices.
Medical Devices
8,633 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Women's Health & Wellness
1,493 items
Startups focused on providing products and services catering to women's health and wellbeing.
Health IT
7,901 items
OCON Medical Patents
OCON Medical has filed 6 patents.
The 3 most popular patent topics include:
- Dosage forms
- Gynaecology
- Drug delivery devices
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
1/14/2022 | 5/9/2023 | Gynaecology, Progestogens, Hormonal contraception, Women's health, Dosage forms | Grant |
Application Date | 1/14/2022 |
|---|---|
Grant Date | 5/9/2023 |
Title | |
Related Topics | Gynaecology, Progestogens, Hormonal contraception, Women's health, Dosage forms |
Status | Grant |
Latest OCON Medical News
May 15, 2023
News provided by Share this article Share this article NEW YORK, May 14, 2023 /PRNewswire/ -- The intrauterine contraceptive devices (IUD) market size is estimated to grow by USD 965.49 million during 2023-2027. However, the growth momentum will be progressing at a CAGR of 3.98% during the forecast period. The market is segmented by Type (Hormonal intrauterine device and Copper intrauterine device), End-user (Hospitals, Gynecology Clinics, and Others), and Geography (North America, Europe, APAC, and Rest of the World (ROW)). The intrauterine devices market share growth by the hormonal intrauterine device segment will be significant during the forecast period. Information Services Market Insights - Vendors: 15+, Including AbbVie Inc., Bayer AG, DKT International, Durbin PLC, EurimPharm Arzneimittel GmbH, EUROGINE SL, Gima Spa, HLL Lifecare Ltd., Krishco Medical Products Pvt. Ltd., Laboratoire HRA Pharma SAS, Melbea Innovations Ltd., Meril Life Sciences Pvt. Ltd., Ocon Medical Ltd., Pregna International Ltd, Prosan International BV, SMB Corp. of India, TESPRO LLC, The Cooper Companies Inc., TRIMEDIC SUPPLY NETWORK Ltd., Viatris Inc., among others Coverage: Parent market analysis; key drivers, major trends, and challenges; customer and vendor landscape; vendor product insights and recent developments; key vendors; and market positioning of vendors Segments: Type (Hormonal intrauterine device and Copper intrauterine device), End-user (Hospitals, Gynecology clinics, and Others), and Geography (North America, Europe, APAC, and Rest of World (ROW)) Insights on the market contribution of various segments, including country- and region-wise data, historic data (2017 to 2021), and forecast market size (2023 to 2027), request a sample report Intrauterine contraceptive devices (IUD) market - Customer Landscape To help companies evaluate and develop growth strategies, the report outlines – Key purchase criteria What are the key data covered in this Intrauterine Contraceptive Devices (IUD) Market report? CAGR of the market during the forecast period Detailed information on factors that will drive the growth of the Intrauterine Contraceptive Devices (IUD) Market between 2023 and 2027 Precise estimation of the size of the Intrauterine Contraceptive Devices (IUD) Market size and its contribution to the market in focus on the parent market Accurate predictions about upcoming trends and changes in consumer behavior Growth of the Intrauterine Contraceptive Devices (IUD) Market industry across North America, Europe, APAC, and Rest of World (ROW) A thorough analysis of the market's competitive landscape and detailed information about vendors Comprehensive analysis of factors that will challenge the growth of Intrauterine Contraceptive Devices (IUD) Market vendors Gain instant access to 17,000+ market research reports. Related Reports: Female Contraceptive Market - The Female Contraceptive Market is estimated to grow at a CAGR of 5.32% between 2022 and 2027. The size of the market is forecast to increase by USD 5,142.22 million. Emergency Contraceptive Pills Market - The emergency contraceptive pills market is estimated to grow at a CAGR of 4.83% between 2022 and 2027. The size of the market is forecast to increase by USD 258.7 million. Intrauterine Contraceptive Devices (IUD) Market Scope Report Coverage Key companies profiled AbbVie Inc., Bayer AG, DKT International, Durbin PLC, EurimPharm Arzneimittel GmbH, EUROGINE SL, Gima Spa, HLL Lifecare Ltd., Krishco Medical Products Pvt. Ltd., Laboratoire HRA Pharma SAS, Melbea Innovations Ltd., Meril Life Sciences Pvt. Ltd., Ocon Medical Ltd., Pregna International Ltd, Prosan International BV, SMB Corp. of India, TESPRO LLC, The Cooper Companies Inc., TRIMEDIC SUPPLY NETWORK Ltd., and Viatris Inc. Market dynamics Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period Customization purview If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Contact
OCON Medical Frequently Asked Questions (FAQ)
When was OCON Medical founded?
OCON Medical was founded in 2011.
Where is OCON Medical's headquarters?
OCON Medical's headquarters is located at Hamiktso’ot Blvd. 14, Modi'In.
What is OCON Medical's latest funding round?
OCON Medical's latest funding round is Seed VC - II.
How much did OCON Medical raise?
OCON Medical raised a total of $3.68M.
Who are the investors of OCON Medical?
Investors of OCON Medical include Pontifax, Astia Angels, Rhia Ventures, Israel Innovation Authority, Docor International Management and 4 more.
Who are OCON Medical's competitors?
Competitors of OCON Medical include Bayer and 2 more.
What products does OCON Medical offer?
OCON Medical's products include IUB SEAD and 4 more.
Compare OCON Medical to Competitors
GynTools develops microscopy-based diagnostic tools for women's health. It offers a patient-centric automated solution for detecting various diagnoses behind vaginal inflammation presenting with discharge, itch, or pain. It was founded in 2016 and is based in Jerusalem, Israel.
Qlarity Imaging improves patient care by extracting clinical insights from existing medical images. It builds products that give radiologists information they do not have access to today.
CapeRay develops the PantoScanner platform, breast imaging technology to detect malignant cancer in dense breast tissue.
Koning is a global health technology company that focuses on improving the breast imaging industry with its patented Koning Breast CT (KBCT). Koning's vision is to create a revolution in medical imaging through advanced computed tomography technology that dramatically improves the way clinicians visualize and evaluate breast tissue.
Growers Edge provides financial technology and data solutions. It assists in decision-making and risk management in areas such as crop plans, credit and financing, and farmland valuation. The company serves agriculture retailers, input manufacturers, and farmers. It was formerly known as Crop Pro Insurance Services. The company was founded in 2016 and is based in Johnston, Iowa.
Attgeno is a Stockholm-headquartered pharmaceutical company.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.